Page last updated: 2024-11-04

sb 202190 and Encephalitis, Herpes Simplex

sb 202190 has been researched along with Encephalitis, Herpes Simplex in 1 studies

4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase

Encephalitis, Herpes Simplex: An acute (or rarely chronic) inflammatory process of the brain caused by SIMPLEXVIRUS infections which may be fatal. The majority of infections are caused by human herpesvirus 1 (HERPESVIRUS 1, HUMAN) and less often by human herpesvirus 2 (HERPESVIRUS 2, HUMAN). Clinical manifestations include FEVER; HEADACHE; SEIZURES; HALLUCINATIONS; behavioral alterations; APHASIA; hemiparesis; and COMA. Pathologically, the condition is marked by a hemorrhagic necrosis involving the medial and inferior TEMPORAL LOBE and orbital regions of the FRONTAL LOBE. (From Adams et al., Principles of Neurology, 6th ed, pp751-4)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lokensgard, JR1
Hu, S1
Sheng, W1
vanOijen, M1
Cox, D1
Cheeran, MC1
Peterson, PK1

Other Studies

1 other study available for sb 202190 and Encephalitis, Herpes Simplex

ArticleYear
Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus.
    Journal of neurovirology, 2001, Volume: 7, Issue:3

    Topics: Astrocytes; Brain; Butadienes; Cell Death; Cells, Cultured; Chemokine CCL5; Chemokine CXCL10; Chemok

2001